Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

A Phase IV, Randomized, Open-Label, Multi-Center Study in Adults: Evaluation of Long-Term Immunogenicity in Subjects Boosted With a New TBE Vaccine for Adults (Free of Protein-Derived Stabilizer) in Study V48P2E1, 5 Years After First Booster Immunization and Evaluation of Booster Kinetics in Subjects Boosted With a New TBE Vaccine for Adults (Free of Protein-Derived Stabilizer), 5 Years After First Booster Immunization

The purpose of this study it is to evalutate the persistence of antibodies after a booster immunisation with a TBE vaccine for adults

Inclusion Criteria:

• Healthy volunteers of both sexes aged >18 who participated in another study on TBE vaccination

Exclusion Criteria:

• Subjects with any condition, in the opinion of the Investigator, might interfere with the evaluation of the study objectives.